主要股东
注：以下部分股东代表特定权益共同体，直接或间接持有上市公司股份
| 序号 | 股东名称 | 是否机构 | 持股数(股) | 持股比例 | 持股变动数(股) | 持股数变动比例 | 投票权比例 |
|---|---|---|---|---|---|---|---|
| 1 | Perceptive Life Sciences Master Fund, Ltd | 是 | 392.72万 | 11.10% | 新增 | 新增 | -- |
| 2 | Gilad Hayeem | 否 | 357.84万 | 10.10% | 新增 | 新增 | -- |
| 3 | Matthew Arnold | 否 | 339.63万 | 9.60% | 新增 | 新增 | -- |
| 4 | JPMC Strategic Investments II Corporation | 是 | 303.16万 | 8.50% | 新增 | 新增 | -- |
| 5 | Rajeev Shah | 否 | 268.94万 | 7.60% | 新增 | 新增 | -- |
| 6 | Adam Koppel | 否 | 198.94万 | 5.60% | 新增 | 新增 | -- |
| 7 | BCLS SB Investco, LP | 是 | 198.94万 | 5.60% | 新增 | 新增 | -- |
| 8 | Biogen New Ventures Inc. | 是 | 177.25万 | 5.00% | 新增 | 新增 | -- |
内部人交易
| 日期 | 股东名称 | 变动股数(万股) | 交易后持股数量(万股) | 交易价格 | 是否直接持有 | 内部人类型 |
|---|---|---|---|---|---|---|
| 2025-12-02 | Herzich Paul |
|
2.93 | -- | 是 | Chief Technology Officer |
| 2025-12-02 | Herzich Paul |
|
2.66 | 5.11 | 是 | Chief Technology Officer |
| 2025-12-02 | Hanrahan Jessie |
|
2.67 | 5.11 | 是 | Chief Regulatory Officer |
| 2025-12-02 | Hanrahan Jessie |
|
3.11 | -- | 是 | Chief Regulatory Officer |
| 2025-11-10 | Ganot Ilan |
|
9.54 | 4.12 | 是 | -- |
| 2025-10-18 | Brooks Gabriel |
|
3.67 | -- | 是 | Chief Medical Officer |
| 2025-10-18 | Brooks Gabriel |
|
3.38 | 5.96 | 是 | Chief Medical Officer |
| 2025-10-06 | SMITH IAN F |
|
12.67 | -- | 是 | -- |
| 2025-07-06 | SMITH IAN F |
|
12.21 | -- | 是 | -- |
| 2025-04-06 | SMITH IAN F |
|
11.75 | -- | 是 | -- |
| 2025-03-11 | Kahn Clare |
|
0.30 | 5.34 | 是 | -- |
| 2025-02-13 | Tan Kevin |
|
3.54 | -- | 是 | CFO & Treasurer |
| 2025-02-13 | Tan Kevin |
|
3.23 | 3.96 | 是 | CFO & Treasurer |
| 2025-02-13 | Brooks Gabriel |
|
2.61 | -- | 是 | Chief Medical Officer |
| 2025-02-13 | Brooks Gabriel |
|
2.28 | 3.96 | 是 | Chief Medical Officer |
| 2025-02-13 | Hanrahan Jessie |
|
1.93 | 3.96 | 是 | Chief Regulatory Officer |
| 2025-02-13 | Hanrahan Jessie |
|
2.24 | -- | 是 | Chief Regulatory Officer |
| 2025-02-13 | Howton David T |
|
3.04 | -- | 是 | Chief Operating Officer |
| 2025-02-13 | Howton David T |
|
2.48 | 3.96 | 是 | Chief Operating Officer |
| 2025-02-13 | Cumbo Alexander |
|
7.21 | -- | 是 | President and CEO |
| 2025-02-13 | Cumbo Alexander |
|
6.07 | 3.96 | 是 | President and CEO |
| 2025-02-13 | Herzich Paul |
|
2.11 | -- | 是 | Chief Technology Officer |
| 2025-02-13 | Herzich Paul |
|
1.84 | 3.96 | 是 | Chief Technology Officer |
| 2025-01-27 | Ganot Ilan |
|
9.87 | -- | 是 | -- |
| 2025-01-09 | Tan Kevin |
|
2.89 | -- | 是 | CFO & Treasurer |
| 2025-01-09 | Tan Kevin |
|
2.48 | 3.89 | 是 | CFO & Treasurer |
| 2025-01-03 | SMITH IAN F |
|
11.30 | -- | 是 | -- |
| 2024-12-02 | Herzich Paul |
|
1.50 | -- | 是 | Chief Technology Officer |
| 2024-12-02 | Herzich Paul |
|
1.22 | 5.60 | 是 | Chief Technology Officer |
| 2024-12-02 | Howton David T |
|
2.07 | -- | 是 | Chief Operating Officer |
| 2024-12-02 | Howton David T |
|
1.57 | 5.60 | 是 | Chief Operating Officer |
| 2024-12-02 | Cumbo Alexander |
|
4.96 | -- | 是 | President and CEO |
| 2024-12-02 | Cumbo Alexander |
|
3.85 | 5.60 | 是 | President and CEO |
| 2024-12-02 | Hanrahan Jessie |
|
1.88 | -- | 是 | Chief Regulatory Officer |
| 2024-12-02 | Hanrahan Jessie |
|
1.42 | 5.60 | 是 | Chief Regulatory Officer |
| 2024-10-18 | Brooks Gabriel |
|
1.39 | -- | 是 | Chief Medical Officer |
| 2024-10-18 | Brooks Gabriel |
|
1.10 | 6.50 | 是 | Chief Medical Officer |
| 2024-10-03 | SMITH IAN F |
|
10.97 | -- | 是 | -- |
| 2024-07-03 | SMITH IAN F |
|
10.65 | -- | 是 | -- |
| 2024-06-07 | Kahn Clare |
|
0.11 | 7.67 | 是 | -- |
| 2024-04-03 | SMITH IAN F |
|
10.32 | -- | 是 | -- |
| 2024-01-27 | Ganot Ilan |
|
9.48 | -- | 是 | -- |
| 2024-01-09 | Tan Kevin |
|
1.32 | -- | 是 | CFO & Treasurer |
| 2024-01-09 | Tan Kevin |
|
0.93 | 8.20 | 是 | CFO & Treasurer |
| 2024-01-03 | SMITH IAN F |
|
9.99 | -- | 是 | -- |